ANH DAO LE, PHARM.D
Pharmacy at Imperial Hwy, La Mirada, CA

License number

California 52931

Professional information

Communications Engineer At Parsons Brinckerhoff

Position:

Communications Engineer at Parsons Brinckerhoff

Location:

Orange County, California Area

Industry:

Transportation/Trucking/Railroad

Work:

Parsons Brinckerhoff since 2010 - Communications Engineer DART 2007 - 2010 - Communications Consultant Sprint Nextel - Irvine, California Area Apr 2005 - Jun 2007 - RF Engineer

Skills:

Telecommunications, Wireless, Project Planning, Engineering

Anh Le

Location:

Orange County, California Area

Industry:

Biotechnology

Skills:

Drug Discovery, Biotechnology, Clinical Development, Lifesciences, Cross-functional Team Leadership, Pharmaceutical Industry, Project Management, Program Management, Validation, R&D, GLP, Microsoft Office, Oncology, Project Planning, GMP, Molecular Biology, Process Improvement, Project Coordination, Healthcare Information Technology, Biochemistry, Cell Biology

Languages:

Vietnamese

Student At West Coast University

Location:

Orange County, California Area

Industry:

Medical Practice

Education:

West Coast University 2010 - 2013

Tech Lead At Wachovia

Position:

Tech Lead at Wachovia

Location:

Orange County, California Area

Industry:

Banking

Work:

Wachovia - Tech Lead

Anh Le, Pico Rivera CA

Specialties:

Pediatrician

Address:

9436 Slauson Ave, Pico Rivera, CA 90660
4950 W Sunset Blvd, Los Angeles, CA 90027
2720 S Bristol St, Santa Ana, CA 92704

Pharmaceutical Compositions Comprising Gingiva A-Derived Mesenchymal Stem Cells And Methods Of Treating Inflammation, Wound Healing And Contact Hypersensitivity

US Patent:

2013029, Nov 7, 2013

Filed:

Jul 14, 2011

Appl. No.:

13/809876

Inventors:

Anh D. Le - La Mirada CA, US
Qunzhou Zhang - San Gabriel CA, US

Assignee:

UNIVERSITY OF SOUTHERN CALIFORNIA - Los Angeles CA

International Classification:

A61K 35/28

US Classification:

424 937, 435375

Abstract:

Disclosed are methods of polarizing macrophages to exhibit M2 phenotype, including introducing an effective amount of gingiva-derived mesenchymal stem cells to an environment comprising a population of macrophages such that the macrophages are in fluid communication with the gingiva-derived mesenchymal stem cells. Also disclosed are methods of promoting cutaneous wound healing including administering to a patient an effective amount of human gingiva-derived mesenchymal stem cells, thereby resulting in at least one of accelerated wound closure, rapid re-epithelialization, improved angiogenesis and improved tissue remodeling relative to untreated controls. Also disclosed are methods for attenuating contact hypersensitivity in a patient, the methods including administering to a patient an effective amount of human gingiva-derived mesenchymal stem cells at a time at least timeframe selected from the group consisting of before sensitization, after sensitization and before challenge and after challenge, thereby attenuating contact hypersensitity.

Anh Le

Location:

Orange County, California Area

Industry:

Insurance

Skills:

Network Administration, VMware, Disaster Recovery, Active Directory, SDLC, Data Center

Certifications:

ITIL V3, MCITP Enterprise Administrator

Gingiva Derived Stem Cell And Its Application In Immunodulation And Reconstruction

US Patent:

2012012, May 24, 2012

Filed:

Jan 20, 2010

Appl. No.:

13/145541

Inventors:

Anh D. Le - La Mirada CA, US
Qunzhou Zhang - South Pasadena CA, US
Songtao Shi - Irvine CA, US

Assignee:

UNIVERSITY OF SOUTHERN CALIFORNIA - Los Angeles CA

International Classification:

A61K 35/12, A61P 1/00, A61P 3/10, A61P 19/02, C12N 5/0775, A61P 29/00

US Classification:

424 937, 435325

Abstract:

The present invention relates to gingiva derived messenchymal stem cells (GMSCs). More specifically, the invention provides compositions and methods of using GMSCs to regulate inflammatory response in the setting of normal versus pathological wound healing and to treat inflammatory and/or autoimmune diseases.